Melita Sun Jung - Feb 2, 2023 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Role
Chief Business Officer
Signature
Jun Yoon, Attorney-in-Fact
Stock symbol
GPCR
Transactions as of
Feb 2, 2023
Transactions value $
$0
Form type
3
Date filed
2/2/2023, 05:19 PM
Next filing
Feb 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GPCR Stock option (right to buy) Feb 2, 2023 Ordinary Shares 465K $1.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4th of the shares vested one year after May 6, 2021 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.